Patients with lung cancer are especially vulnerable to coronavirus disease 2019 (COVID-19)
with a greater than sevenfold higher rate of becoming infected with severe acute respiratory …

Patients with cancer are more susceptible to a higher risk of coronavirus infection and its
severe complications than the general population. In addition, these patients were not …

Background Patients with solid tumours have high COVID-19 mortality. Limited and
heterogeneous data are available regarding the immunogenicity of SARS-CoV-2 mRNA …

Purpose: Recommendations and guidelines consider cancer patients a high-priority
population for COVID-19 immunization. Vaccination process in Serbia began in January …

Introduction Pregnancy-associated breast cancer (PABC) encompasses breast cancer
diagnosed during pregnancy (BCP) or postpartum (PPBC). BCP is especially challenging …

Highlights•Significant inequity is observed in vaccine distribution and administration
worldwide.•Delta variant dominance and waning vaccine efficacy against infection raise the …

Abstract Background Coronavirus disease 2019 (COVID-19) pandemic affected millions of
individuals, and patients with cancer are known to be more susceptible. Vaccines against …

Background Cancer is associated with excess morbidity and mortality from coronavirus
disease 2019 (COVID-19) following infection by the novel pandemic coronavirus SARS-CoV …

(1) Background: The appearance of enlarged lymph nodes on imaging adds another layer of
complexity to the differential diagnosis of disease progression versus immune response to …

Objective Patients with lung cancer are at increased risk of SARS-CoV-2 infection and
severe complications from COVID-19, but information on the efficacy of anti-SARS-CoV-2 …